{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:16:44Z","timestamp":1790425004784,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human T cell lymphotropic virus 1 (HTLV-1) is a human retrovirus and infects approximately 10\u201320\u00a0million people worldwide. While the majority of infected people are asymptomatic carriers of HTLV-1, only 4% of infected people develop HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). HAM\/TSP is a chronic, progressive, neurological disease which usually progresses slowly without remission, and is characterized by perivascular inflammatory infiltrates in chronic inflammatory lesions of the central nervous system (CNS), primarily affecting the spinal cord. A high HTLV-1 proviral load, high levels of antibodies against HTLV-1 antigens, and elevated concentration of proteins are detected in cerebrospinal fluid (CSF) of HAM\/TSP patients. These chronically activated immune responses against HTLV-1 and infiltration of inflammatory cells including HTLV-1 infected cells into the CNS contribute to clinical disability and underlie the pathogenesis of HAM\/TSP. Since the disease development of HAM\/TSP mainly occurs in adults, with a mean age at onset of 40\u201350\u00a0years, it is important for HTLV-1-infected carriers and HAM\/TSP patients to be monitored throughout the disease process. Recent advances in technologies and findings provide new insights to virological and immunological aspects in both the CNS as well as in peripheral blood. In this review, we focus on understanding the inflammatory milieu in the CNS and discuss the immunopathogenic process in HTLV-1-associated neurologic diseases.<\/jats:p>","DOI":"10.1186\/s12977-019-0499-5","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T16:02:48Z","timestamp":1575043368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Immunovirological markers in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)"],"prefix":"10.1186","volume":"16","author":[{"given":"Yoshimi","family":"Enose-Akahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-1287","authenticated-orcid":false,"given":"Steven","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"499_CR1","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological Aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"key":"499_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985;2:407\u201310.","journal-title":"Lancet"},{"key":"499_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986;1:1031\u20132.","journal-title":"Lancet"},{"key":"499_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0268-960X(88)90012-4","volume":"2","author":"T Uchiyama","year":"1988","unstructured":"Uchiyama T. Adult T-cell leukemia. Blood Rev. 1988;2:232\u20138.","journal-title":"Blood Rev"},{"key":"499_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993;52:424\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"key":"499_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","volume":"3","author":"Y Yamano","year":"2012","unstructured":"Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol. 2012;3:389.","journal-title":"Front Microbiol"},{"key":"499_CR8","first-page":"1096","volume":"3","author":"JE Kaplan","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr. 1990;3:1096\u2013101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"499_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","volume":"17","author":"EM Maloney","year":"1998","unstructured":"Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A. Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:167\u201370.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"499_CR10","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","volume":"61","author":"JR Orland","year":"2003","unstructured":"Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C, Garratty G, Newman B, Smith D, Wang B, et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV outcomes study. Neurology. 2003;61:1588\u201394.","journal-title":"Neurology"},{"key":"499_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/jnnp.53.1.4","volume":"53","author":"K Kayembe","year":"1990","unstructured":"Kayembe K, Goubau P, Desmyter J, Vlietinck R, Carton H. A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry. 1990;53:4\u201310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"499_CR12","doi-asserted-by":"publisher","first-page":"e0006304","DOI":"10.1371\/journal.pntd.0006304","volume":"12","author":"S Olindo","year":"2018","unstructured":"Olindo S, Jeannin S, Saint-Vil M, Signate A, Edimonana-Kaptue M, Joux J, Merle H, Richard P, Granjeaud S, Cabre P, et al. Temporal trends in human T-lymphotropic virus 1 (HTLV-1) associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) incidence in Martinique over 25\u00a0years (1986-2010). PLoS Negl Trop Dis. 2018;12:e0006304.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/aid.2013.0086","volume":"29","author":"LC Romanelli","year":"2013","unstructured":"Romanelli LC, Caramelli P, Martins ML, Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Carneiro-Proietti AB. Incidence of human T cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil. AIDS Res Hum Retrovir. 2013;29:1199\u2013202.","journal-title":"AIDS Res Hum Retrovir"},{"key":"499_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5694\/mja16.00285","volume":"205","author":"LJ Einsiedel","year":"2016","unstructured":"Einsiedel LJ, Pham H, Woodman RJ, Pepperill C, Taylor KA. The prevalence and clinical associations of HTLV-1 infection in a remote indigenous community. Med J Aust. 2016;205:305\u20139.","journal-title":"Med J Aust"},{"key":"499_CR15","doi-asserted-by":"publisher","first-page":"e2643","DOI":"10.1371\/journal.pntd.0002643","volume":"8","author":"L Einsiedel","year":"2014","unstructured":"Einsiedel L, Spelman T, Goeman E, Cassar O, Arundell M, Gessain A. Clinical associations of human T-Lymphotropic virus type 1 infection in an indigenous Australian population. PLoS Negl Trop Dis. 2014;8:e2643.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12977-016-0290-9","volume":"13","author":"Y Enose-Akahata","year":"2016","unstructured":"Enose-Akahata Y, Caruso B, Haner B, Charlip E, Nair G, Massoud R, Billioux BJ, Ohayon J, Switzer WM, Jacobson S. Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1). Retrovirology. 2016;13:56.","journal-title":"Retrovirology"},{"key":"499_CR17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/JVI.64.3.1278-1282.1990","volume":"64","author":"S Daenke","year":"1990","unstructured":"Daenke S, Nightingale S, Cruickshank JK, Bangham CR. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990;64:1278\u201382.","journal-title":"J Virol"},{"key":"499_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1212\/WNL.43.12.2621","volume":"43","author":"M Nishimura","year":"1993","unstructured":"Nishimura M, McFarlin DE, Jacobson S. Sequence comparisons of HTLV-I from HAM\/TSP patients and their asymptomatic spouses. Neurology. 1993;43:2621\u20134.","journal-title":"Neurology"},{"key":"499_CR19","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1136\/jnnp.2009.191239","volume":"81","author":"F Martin","year":"2010","unstructured":"Martin F, Fedina A, Youshya S, Taylor GP. A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK. J Neurol Neurosurg Psychiatry. 2010;81:1336\u201340.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"499_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/13550280152403272","volume":"7","author":"T Matsuzaki","year":"2001","unstructured":"Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, Arimura K, Kubota H, Izumo S, Akiba S, Osame M. HTLV-I proviral load correlates with progression of motor disability in HAM\/TSP: analysis of 239 HAM\/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 2001;7:228\u201334.","journal-title":"J Neurovirol"},{"key":"499_CR21","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA. 1999;96:3848\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR22","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","volume":"165","author":"KJ Jeffery","year":"2000","unstructured":"Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000;165:7278\u201384.","journal-title":"J Immunol"},{"key":"499_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-008-0096-z","volume":"198","author":"BC Catalan-Soares","year":"2009","unstructured":"Catalan-Soares BC, Carneiro-Proietti AB, Da Fonseca FG, Correa-Oliveira R, Peralva-Lima D, Portela R, Ribas JG, Goncalves DU, Interdisciplinary HRG, Proietti FA. HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med Microbiol Immunol. 2009;198:1\u20133.","journal-title":"Med Microbiol Immunol"},{"key":"499_CR24","doi-asserted-by":"publisher","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","volume":"6","author":"A Macnamara","year":"2010","unstructured":"Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CR, Asquith B. HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010;6:e1001117.","journal-title":"PLoS Pathog"},{"key":"499_CR25","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00415-013-7014-z","volume":"260","author":"A Trevino","year":"2013","unstructured":"Trevino A, Vicario JL, Lopez M, Parra P, Benito R, de Lejarazu RO, Ramos JM, Del Romero J, de Mendoza C, Soriano V. Association between HLA alleles and HAM\/TSP in individuals infected with HTLV-1. J Neurol. 2013;260:2551\u20135.","journal-title":"J Neurol"},{"key":"499_CR26","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/423942","volume":"190","author":"AH Sabouri","year":"2004","unstructured":"Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, et al. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis. 2004;190:1279\u201385.","journal-title":"J Infect Dis"},{"key":"499_CR27","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/jmv.21341","volume":"80","author":"SR Gadelha","year":"2008","unstructured":"Gadelha SR, Junior Alcantara LC, Costa GC, Acosta AX, Rios D, Kashima S, Covas DT, Galvao-Castro B. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis in Brazilian individuals. J Med Virol. 2008;80:2141\u20136.","journal-title":"J Med Virol"},{"key":"499_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1086\/342953","volume":"186","author":"AM Vine","year":"2002","unstructured":"Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis. 2002;186:932\u20139.","journal-title":"J Infect Dis"},{"key":"499_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12977-017-0350-9","volume":"14","author":"S Nozuma","year":"2017","unstructured":"Nozuma S, Matsuura E, Kodama D, Tashiro Y, Matsuzaki T, Kubota R, Izumo S, Takashima H. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy\/tropical spastic paraparesis. Retrovirology. 2017;14:26.","journal-title":"Retrovirology"},{"key":"499_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s004019900170","volume":"100","author":"MM Aye","year":"2000","unstructured":"Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol. 2000;100:245\u201352.","journal-title":"Acta Neuropathol"},{"key":"499_CR31","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/infdis\/157.6.1226","volume":"157","author":"A Gessain","year":"1988","unstructured":"Gessain A, Caudie C, Gout O, Vernant JC, Maurs L, Giordano C, Malone G, Tournier-Lasserve E, Essex M, de-The G. Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis. 1988;157:1226\u201334.","journal-title":"J Infect Dis"},{"key":"499_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000054813","volume":"21","author":"AC Milagres","year":"2002","unstructured":"Milagres AC, Jorge ML, Marchiori PE, Segurado AA. Human T cell lymphotropic virus type 1-associated myelopathy in Sao Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort. Neuroepidemiology. 2002;21:153\u20138.","journal-title":"Neuroepidemiology"},{"key":"499_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol. 1995;1:50\u201361.","journal-title":"J Neurovirol"},{"key":"499_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.25072","volume":"82","author":"S Azodi","year":"2017","unstructured":"Azodi S, Nair G, Enose-Akahata Y, Charlip E, Vellucci A, Cortese I, Dwyer J, Billioux BJ, Thomas C, Ohayon J, et al. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM\/TSP) and multiple sclerosis (MS). Ann Neurol. 2017;82:719\u201328.","journal-title":"Ann Neurol"},{"key":"499_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.24213","volume":"76","author":"W Liu","year":"2014","unstructured":"Liu W, Nair G, Vuolo L, Bakshi A, Massoud R, Reich DS, Jacobson S. In vivo imaging of spinal cord atrophy in neuroinflammatory diseases. Ann Neurol. 2014;76:370\u20138.","journal-title":"Ann Neurol"},{"key":"499_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13365-014-0282-2","volume":"20","author":"C Vilchez","year":"2014","unstructured":"Vilchez C, Gonzalez-Reinoso M, Cubbison C, Perez-Then E, Roa P, Martinez A, Foerster B, Oviedo J, Stoeter P. Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). J Neurovirol. 2014;20:583\u201390.","journal-title":"J Neurovirol"},{"key":"499_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4:586\u201393.","journal-title":"J Neurovirol"},{"key":"499_CR38","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/aid.2012.0132","volume":"29","author":"MA Demontis","year":"2013","unstructured":"Demontis MA, Hilburn S, Taylor GP. Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases. AIDS Res Hum Retrovir. 2013;29:359\u201364.","journal-title":"AIDS Res Hum Retrovir"},{"key":"499_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s13365-016-0484-x","volume":"23","author":"ML Martins","year":"2017","unstructured":"Martins ML, Guimaraes JC, Ribas JG, Romanelli LC, de Freitas Carneiro-Proietti AB. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM\/TSP: what is its relevance as a prognostic marker for neurologic disease? J Neurovirol. 2017;23:125\u201333.","journal-title":"J Neurovirol"},{"key":"499_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13365-014-0249-3","volume":"20","author":"GS Brunetto","year":"2014","unstructured":"Brunetto GS, Massoud R, Leibovitch EC, Caruso B, Johnson K, Ohayon J, Fenton K, Cortese I, Jacobson S. Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM\/TSP patients and identification of viral mutations. J Neurovirol. 2014;20:341\u201351.","journal-title":"J Neurovirol"},{"key":"499_CR41","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1086\/429962","volume":"191","author":"A Lezin","year":"2005","unstructured":"Lezin A, Olindo S, Oliere S, Varrin-Doyer M, Marlin R, Cabre P, Smadja D, Cesaire R. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis? J Infect Dis. 2005;191:1830\u20134.","journal-title":"J Infect Dis"},{"key":"499_CR42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ana.10065","volume":"50","author":"M Nagai","year":"2001","unstructured":"Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S. Increased HTLV-I proviral load and preferential expansion of HTLV-I tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP. Ann Neurol. 2001;50:807\u201312.","journal-title":"Ann Neurol"},{"key":"499_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13550280390173418","volume":"9","author":"N Takenouchi","year":"2003","unstructured":"Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 2003;9:29\u201335.","journal-title":"J Neurovirol"},{"key":"499_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/01.wnl.0000251300.24540.c4","volume":"68","author":"M Puccioni-Sohler","year":"2007","unstructured":"Puccioni-Sohler M, Yamano Y, Rios M, Carvalho SM, Vasconcelos CC, Papais-Alvarenga R, Jacobson S. Differentiation of HAM\/TSP from patients with multiple sclerosis infected with HTLV-I. Neurology. 2007;68:206\u201313.","journal-title":"Neurology"},{"key":"499_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270\u201380.","journal-title":"Nat Rev Cancer"},{"key":"499_CR46","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1089\/08892220050193191","volume":"16","author":"E Hanon","year":"2000","unstructured":"Hanon E, Asquith RE, Taylor GP, Tanaka Y, Weber JN, Bangham CR. High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retrovir. 2000;16:1711\u20135.","journal-title":"AIDS Res Hum Retrovir"},{"key":"499_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood. 2002;99:88\u201394.","journal-title":"Blood"},{"key":"499_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00705-004-0443-3","volume":"150","author":"L Cartier","year":"2005","unstructured":"Cartier L, Ramirez E. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM\/TSP patients. Arch Virol. 2005;150:743\u201353.","journal-title":"Arch Virol"},{"key":"499_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.410370206","volume":"37","author":"TJ Lehky","year":"1995","unstructured":"Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol. 1995;37:167\u201375.","journal-title":"Ann Neurol"},{"key":"499_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/13550289909015810","volume":"5","author":"T Moritoyo","year":"1999","unstructured":"Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M, Osame M. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 1999;5:241\u20138.","journal-title":"J Neurovirol"},{"key":"499_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009;6:19.","journal-title":"Retrovirology"},{"key":"499_CR52","doi-asserted-by":"publisher","first-page":"e0005285","DOI":"10.1371\/journal.pntd.0005285","volume":"11","author":"M Baratella","year":"2017","unstructured":"Baratella M, Forlani G, Raval GU, Tedeschi A, Gout O, Gessain A, Tosi G, Accolla RS. Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). PLoS Negl Trop Dis. 2017;11:e0005285.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR53","doi-asserted-by":"publisher","first-page":"e1000027","DOI":"10.1371\/journal.ppat.1000027","volume":"4","author":"KN Meekings","year":"2008","unstructured":"Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CR. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM\/TSP. PLoS Pathog. 2008;4:e1000027.","journal-title":"PLoS Pathog"},{"key":"499_CR54","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CR. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117:3113\u201322.","journal-title":"Blood"},{"key":"499_CR55","doi-asserted-by":"publisher","first-page":"e1003271","DOI":"10.1371\/journal.ppat.1003271","volume":"9","author":"A Melamed","year":"2013","unstructured":"Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013;9:e1003271.","journal-title":"PLoS Pathog"},{"key":"499_CR56","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1073\/pnas.1423199113","volume":"113","author":"Y Satou","year":"2016","unstructured":"Satou Y, Miyazato P, Ishihara K, Yaguchi H, Melamed A, Miura M, Fukuda A, Nosaka K, Watanabe T, Rowan AG, et al. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc Natl Acad Sci USA. 2016;113:3054\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1377\u20131387","key":"499_CR57","first-page":"e1373","volume":"24","author":"A Kulkarni","year":"2017","unstructured":"Kulkarni A, Mateus M, Thinnes CC, McCullagh JS, Schofield CJ, Taylor GP, Bangham CRM. Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1. Cell Chem Biol. 2017;24(1377\u20131387):e1373.","journal-title":"Cell Chem Biol"},{"key":"499_CR58","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fnins.2017.00386","volume":"11","author":"G Minhas","year":"2017","unstructured":"Minhas G, Mathur D, Ragavendrasamy B, Sharma NK, Paanu V, Anand A. Hypoxia in CNS pathologies: emerging role of miRNA-based neurotherapeutics and yoga based alternative therapies. Front Neurosci. 2017;11:386.","journal-title":"Front Neurosci"},{"key":"499_CR59","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","volume":"115","author":"N Manel","year":"2003","unstructured":"Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115:449\u201359.","journal-title":"Cell"},{"key":"499_CR60","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V89.1.346","volume":"89","author":"MC Levin","year":"1997","unstructured":"Levin MC, Krichavsky M, Fox RJ, Lehky T, Jacobson S, Fox C, Kleghorn F, White J, Young N, Edwards RJ, et al. Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease. Blood. 1997;89:346\u20138.","journal-title":"Blood"},{"key":"499_CR61","doi-asserted-by":"publisher","first-page":"e6517","DOI":"10.1371\/journal.pone.0006517","volume":"4","author":"Y Yamano","year":"2009","unstructured":"Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, Izumi T, Fujita H, Aratani S, Yagishita N, et al. Abnormally high levels of virus-infected IFN-gamma+CCR4+CD4+CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS ONE. 2009;4:e6517.","journal-title":"PLoS ONE"},{"key":"499_CR62","doi-asserted-by":"publisher","first-page":"e1007042","DOI":"10.1371\/journal.ppat.1007042","volume":"14","author":"Y Enose-Akahata","year":"2018","unstructured":"Enose-Akahata Y, Azodi S, Smith BR, Billioux BJ, Vellucci A, Ngouth N, Tanaka Y, Ohayon J, Cortese I, Nath A, Jacobson S. Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases. PLoS Pathog. 2018;14:e1007042.","journal-title":"PLoS Pathog"},{"key":"499_CR63","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1172\/JCI75250","volume":"124","author":"N Araya","year":"2014","unstructured":"Araya N, Sato T, Ando H, Tomaru U, Yoshida M, Coler-Reilly A, Yagishita N, Yamauchi J, Hasegawa A, Kannagi M, et al. HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. J Clin Invest. 2014;124:3431\u201342.","journal-title":"J Clin Invest"},{"key":"499_CR64","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest. 2005;115:1361\u20138.","journal-title":"J Clin Invest"},{"key":"499_CR65","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1093\/brain\/awt183","volume":"136","author":"H Ando","year":"2013","unstructured":"Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Shimizu Y, et al. Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain. 2013;136:2876\u201387.","journal-title":"Brain"},{"key":"499_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","volume":"182","author":"S Sakaguchi","year":"2001","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18\u201332.","journal-title":"Immunol Rev"},{"key":"499_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11481-014-9547-z","volume":"9","author":"MR Anderson","year":"2014","unstructured":"Anderson MR, Enose-Akahata Y, Massoud R, Ngouth N, Tanaka Y, Oh U, Jacobson S. Epigenetic modification of the FoxP3 TSDR in HAM\/TSP decreases the functional suppression of Tregs. J Neuroimmune Pharmacol. 2014;9:522\u201332.","journal-title":"J Neuroimmune Pharmacol"},{"key":"499_CR68","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20032042","volume":"199","author":"Y Yamano","year":"2004","unstructured":"Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, Li HC, Reiter Y, Jacobson S. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med. 2004;199:1367\u201377.","journal-title":"J Exp Med"},{"key":"499_CR69","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1182\/blood-2007-11-123430","volume":"111","author":"C Grant","year":"2008","unstructured":"Grant C, Oh U, Yao K, Yamano Y, Jacobson S. Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease. Blood. 2008;111:5601\u20139.","journal-title":"Blood"},{"key":"499_CR70","doi-asserted-by":"publisher","first-page":"e1003630","DOI":"10.1371\/journal.ppat.1003630","volume":"9","author":"N Yamamoto-Taguchi","year":"2013","unstructured":"Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, Kinashi T, Matsuoka M. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013;9:e1003630.","journal-title":"PLoS Pathog"},{"key":"499_CR71","doi-asserted-by":"publisher","first-page":"e1005560","DOI":"10.1371\/journal.ppat.1005560","volume":"12","author":"K Manivannan","year":"2016","unstructured":"Manivannan K, Rowan AG, Tanaka Y, Taylor GP, Bangham CR. CADM1\/TSLC1 identifies HTLV-1-infected cells and determines their susceptibility to CTL-mediated lysis. PLoS Pathog. 2016;12:e1005560.","journal-title":"PLoS Pathog"},{"key":"499_CR72","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1182\/blood-2008-03-136770","volume":"114","author":"M Nejmeddine","year":"2009","unstructured":"Nejmeddine M, Negi VS, Mukherjee S, Tanaka Y, Orth K, Taylor GP, Bangham CR. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood. 2009;114:1016\u201325.","journal-title":"Blood"},{"key":"499_CR73","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1128\/JVI.71.11.8522-8530.1997","volume":"71","author":"H Valentin","year":"1997","unstructured":"Valentin H, Lemasson I, Hamaia S, Casse H, Konig S, Devaux C, Gazzolo L. Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein. J Virol. 1997;71:8522\u201330.","journal-title":"J Virol"},{"key":"499_CR74","doi-asserted-by":"publisher","first-page":"e1005372","DOI":"10.1371\/journal.ppat.1005372","volume":"12","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M. HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). PLoS Pathog. 2016;12:e1005372.","journal-title":"PLoS Pathog"},{"key":"499_CR75","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1128\/JVI.00539-16","volume":"90","author":"C Curis","year":"2016","unstructured":"Curis C, Percher F, Jeannin P, Montange T, Chevalier SA, Seilhean D, Cartier L, Couraud PO, Gout O, Gessain A, et al. Human T-lymphotropic virus type 1-induced overexpression of activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of infected lymphocytes through the blood-brain barrier. J Virol. 2016;90:7303\u201312.","journal-title":"J Virol"},{"key":"499_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990;348:245\u20138.","journal-title":"Nature"},{"key":"499_CR77","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood. 2000;95:1386\u201392.","journal-title":"Blood"},{"key":"499_CR78","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","volume":"173","author":"AM Vine","year":"2004","unstructured":"Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, Witkover A, Thompson G, Saito M, Goon PK, Carr L, et al. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol. 2004;173:5121\u20139.","journal-title":"J Immunol"},{"key":"499_CR79","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-510X(95)00036-2","volume":"130","author":"M Matsui","year":"1995","unstructured":"Matsui M, Nagumo F, Tadano J, Kuroda Y. Characterization of humoral and cellular immunity in the central nervous system of HAM\/TSP. J Neurol Sci. 1995;130:183\u20139.","journal-title":"J Neurol Sci"},{"key":"499_CR80","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","volume":"95","author":"TF Greten","year":"1998","unstructured":"Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients. Proc Natl Acad Sci USA. 1998;95:7568\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR81","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","author":"R Kubota","year":"1998","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol. 1998;161:482\u20138.","journal-title":"J Immunol"},{"key":"499_CR82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0000000000000141","volume":"74","author":"E Matsuura","year":"2015","unstructured":"Matsuura E, Kubota R, Tanaka Y, Takashima H, Izumo S. Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. J Neuropathol Exp Neurol. 2015;74:2\u201314.","journal-title":"J Neuropathol Exp Neurol"},{"key":"499_CR83","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/jiq078","volume":"203","author":"S Hilburn","year":"2011","unstructured":"Hilburn S, Rowan A, Demontis MA, MacNamara A, Asquith B, Bangham CR, Taylor GP. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis. 2011;203:529\u201336.","journal-title":"J Infect Dis"},{"key":"499_CR84","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","volume":"3","author":"TA Waldmann","year":"2015","unstructured":"Waldmann TA. The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy. Cancer Immunol Res. 2015;3:219\u201327.","journal-title":"Cancer Immunol Res"},{"key":"499_CR85","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","volume":"163","author":"N Azimi","year":"1999","unstructured":"Azimi N, Jacobson S, Leist T, Waldmann TA. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor. J Immunol. 1999;163:4064\u201372.","journal-title":"J Immunol"},{"key":"499_CR86","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290\u20137.","journal-title":"Nat Med"},{"issue":"8","key":"499_CR87","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/acn3.50820","volume":"6","author":"Y Enose-Akahata","year":"2019","unstructured":"Enose-Akahata Y, Oh U, Ohayon J, Billioux BJ, Massoud R, Bryant BR, Vellucci A, Ngouth N, Cortese I, Waldmann TA, Jacobson S. Clinical trial of a humanized anti-IL-2\/IL-15 receptor beta chain in HAM\/TSP. Ann Clin Transl Neurol. 2019;6(8):1383\u201394.","journal-title":"Ann Clin Transl Neurol"},{"key":"499_CR88","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41598-018-36274-7","volume":"9","author":"AP Alves Sousa","year":"2019","unstructured":"Alves Sousa AP, Johnson KR, Ohayon J, Zhu J, Muraro PA, Jacobson S. Comprehensive analysis of TCR-beta repertoire in patients with neurological immune-mediated disorders. Sci Rep. 2019;9:344.","journal-title":"Sci Rep"},{"key":"499_CR89","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood.V98.3.721","volume":"98","author":"E Hanon","year":"2001","unstructured":"Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN, Bangham CR. High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood. 2001;98:721\u20136.","journal-title":"Blood"},{"key":"499_CR90","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1074-7613(00)00065-0","volume":"13","author":"E Hanon","year":"2000","unstructured":"Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, Weber JN, Griffiths GM, Bangham CR. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity. 2000;13:657\u201364.","journal-title":"Immunity"},{"key":"499_CR91","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0165-5728(99)00175-7","volume":"102","author":"R Kubota","year":"2000","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S. HTLV-I specific IFN-gamma+CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals. J Neuroimmunol. 2000;102:208\u201315.","journal-title":"J Neuroimmunol"},{"key":"499_CR92","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1182\/blood-2008-02-138529","volume":"112","author":"Y Enose-Akahata","year":"2008","unstructured":"Enose-Akahata Y, Oh U, Grant C, Jacobson S. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood. 2008;112:2400\u201310.","journal-title":"Blood"},{"key":"499_CR93","doi-asserted-by":"publisher","first-page":"14559","DOI":"10.1073\/pnas.251540598","volume":"98","author":"N Azimi","year":"2001","unstructured":"Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM\/TSP patients. Proc Natl Acad Sci USA. 2001;98:14559\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"499_CR94","doi-asserted-by":"publisher","first-page":"e1000682","DOI":"10.1371\/journal.ppat.1000682","volume":"5","author":"Y Enose-Akahata","year":"2009","unstructured":"Enose-Akahata Y, Matsuura E, Oh U, Jacobson S. High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease. PLoS Pathog. 2009;5:e1000682.","journal-title":"PLoS Pathog"},{"key":"499_CR95","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/infdis\/jiq153","volume":"203","author":"NH Abdelbary","year":"2011","unstructured":"Abdelbary NH, Abdullah HM, Matsuzaki T, Hayashi D, Tanaka Y, Takashima H, Izumo S, Kubota R. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. J Infect Dis. 2011;203:948\u201359.","journal-title":"J Infect Dis"},{"key":"499_CR96","doi-asserted-by":"publisher","first-page":"e1030","DOI":"10.1371\/journal.pntd.0001030","volume":"5","author":"LC Ndhlovu","year":"2011","unstructured":"Ndhlovu LC, Leal FE, Hasenkrug AM, Jha AR, Carvalho KI, Eccles-James IG, Bruno FR, Vieira RG, York VA, Chew GM, et al. HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS Negl Trop Dis. 2011;5:e1030.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR97","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","volume":"380","author":"I Cortese","year":"2019","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019;380:1597\u2013605.","journal-title":"N Engl J Med"},{"key":"499_CR98","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.humimm.2011.07.308","volume":"72","author":"T Kozako","year":"2011","unstructured":"Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N. Programmed death-1 (PD-1)\/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders. Hum Immunol. 2011;72:1001\u20136.","journal-title":"Hum Immunol"},{"key":"499_CR99","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1212\/WNL.53.6.1335","volume":"53","author":"M Puccioni-Sohler","year":"1999","unstructured":"Puccioni-Sohler M, Rios M, Bianco C, Zhu SW, Oliveira C, Novis SA, Pombo-de-Oliveira MS. An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP\/HAM. Neurology. 1999;53:1335\u20139.","journal-title":"Neurology"},{"key":"499_CR100","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jneuroim.2008.07.020","volume":"204","author":"S Lee","year":"2008","unstructured":"Lee S, Shin Y, Marler J, Levin MC. Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease. J Neuroimmunol. 2008;204:140\u20138.","journal-title":"J Neuroimmunol"},{"key":"499_CR101","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nm0502-509","volume":"8","author":"MC Levin","year":"2002","unstructured":"Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med. 2002;8:509\u201313.","journal-title":"Nat Med"},{"key":"499_CR102","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF00868998","volume":"243","author":"B Kitze","year":"1996","unstructured":"Kitze B, Usuku K, Izumo S, Nakamura M, Shiraki H, Ijichi S, Yashiki S, Fujiyoshi T, Sonoda S, Osame M. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J Neurol. 1996;243:393\u2013400.","journal-title":"J Neurol"},{"key":"499_CR103","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0165-5728(91)90171-3","volume":"35","author":"M Nakamura","year":"1991","unstructured":"Nakamura M, Kuroki M, Kira J, Itoyama Y, Shiraki H, Kuroda N, Washitani Y, Nakano S, Nagafuchi S, Anzai K, et al. Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM\/TSP. J Neuroimmunol. 1991;35:167\u201377.","journal-title":"J Neuroimmunol"},{"key":"499_CR104","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jneuroim.2004.03.006","volume":"152","author":"J Fujimori","year":"2004","unstructured":"Fujimori J, Nakashima I, Fujihara K, Feng J, Yamamoto M, Yamamoto N, Begum N, Sagara Y, Shiraki H, Shiga Y, et al. Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method. J Neuroimmunol. 2004;152:140\u20136.","journal-title":"J Neuroimmunol"},{"key":"499_CR105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-10-19","volume":"10","author":"Y Enose-Akahata","year":"2013","unstructured":"Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology. 2013;10:19.","journal-title":"Retrovirology"},{"key":"499_CR106","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1212\/WNL.41.3.457","volume":"41","author":"M Nomoto","year":"1991","unstructured":"Nomoto M, Utatsu Y, Soejima Y, Osame M. Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy\/tropical spastic paraparesis. Neurology. 1991;41:457.","journal-title":"Neurology"},{"key":"499_CR107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0165-5728(97)00012-X","volume":"75","author":"A Inoue","year":"1997","unstructured":"Inoue A, Koh CS, Sakai T, Yamazaki M, Yanagisawa N, Usuku K, Osame M. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. J Neuroimmunol. 1997;75:141\u20136.","journal-title":"J Neuroimmunol"},{"key":"499_CR108","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-4690-10-51","volume":"10","author":"M Saito","year":"2013","unstructured":"Saito M, Tanaka R, Arishima S, Matsuzaki T, Ishihara S, Tokashiki T, Ohya Y, Takashima H, Umehara F, Izumo S, Tanaka Y. Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. Retrovirology. 2013;10:51.","journal-title":"Retrovirology"},{"key":"499_CR109","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-5728(93)90014-P","volume":"42","author":"Y Kuroda","year":"1993","unstructured":"Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol. 1993;42:223\u20136.","journal-title":"J Neuroimmunol"},{"key":"499_CR110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0165-5728(93)90173-V","volume":"45","author":"Y Kuroda","year":"1993","unstructured":"Kuroda Y, Matsui M, Takashima H, Kurohara K. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol. 1993;45:133\u20136.","journal-title":"J Neuroimmunol"},{"key":"499_CR111","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","volume":"97","author":"N Nishimoto","year":"1990","unstructured":"Nishimoto N, Yoshizaki K, Eiraku N, Machigashira K, Tagoh H, Ogata A, Kuritani T, Osame M, Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurol Sci. 1990;97:183\u201393.","journal-title":"J Neurol Sci"},{"key":"499_CR112","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0165-5728(93)90001-F","volume":"42","author":"S Nakamura","year":"1993","unstructured":"Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol. 1993;42:127\u201330.","journal-title":"J Neuroimmunol"},{"key":"499_CR113","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994;53:72\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"key":"499_CR114","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jneuroim.2004.10.011","volume":"159","author":"K Narikawa","year":"2005","unstructured":"Narikawa K, Fujihara K, Misu T, Feng J, Fujimori J, Nakashima I, Miyazawa I, Saito H, Sato S, Itoyama Y. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha. J Neuroimmunol. 2005;159:177\u201382.","journal-title":"J Neuroimmunol"},{"key":"499_CR115","doi-asserted-by":"publisher","first-page":"e2479","DOI":"10.1371\/journal.pntd.0002479","volume":"7","author":"T Sato","year":"2013","unstructured":"Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, Yamauchi J, Inoue E, Ueno T, Hasegawa Y, et al. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS Negl Trop Dis. 2013;7:e2479.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR116","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","volume":"71","author":"M Tanaka","year":"2008","unstructured":"Tanaka M, Matsushita T, Tateishi T, Ochi H, Kawano Y, Mei FJ, Minohara M, Murai H, Kira JI. Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology. 2008;71:974\u201381.","journal-title":"Neurology"},{"key":"499_CR117","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3389\/fmicb.2018.01651","volume":"9","author":"T Sato","year":"2018","unstructured":"Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, et al. Proposal of classification criteria for HTLV-1-associated myelopathy\/tropical spastic paraparesis disease activity. Front Microbiol. 2018;9:1651.","journal-title":"Front Microbiol"},{"key":"499_CR118","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s13311-016-0450-6","volume":"13","author":"MR Anderson","year":"2016","unstructured":"Anderson MR, Kashanchi F, Jacobson S. Exosomes in viral disease. Neurotherapeutics. 2016;13:535\u201346.","journal-title":"Neurotherapeutics"},{"key":"499_CR119","doi-asserted-by":"publisher","first-page":"22284","DOI":"10.1074\/jbc.M114.549659","volume":"289","author":"E Jaworski","year":"2014","unstructured":"Jaworski E, Narayanan A, Van Duyne R, Shabbeer-Meyering S, Iordanskiy S, Saifuddin M, Das R, Afonso PV, Sampey GC, Chung M, et al. Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein. J Biol Chem. 2014;289:22284\u2013305.","journal-title":"J Biol Chem"},{"key":"499_CR120","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40169-018-0204-7","volume":"7","author":"MR Anderson","year":"2018","unstructured":"Anderson MR, Pleet ML, Enose-Akahata Y, Erickson J, Monaco MC, Akpamagbo Y, Velluci A, Tanaka Y, Azodi S, Lepene B, et al. Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes. Clin Transl Med. 2018;7:24.","journal-title":"Clin Transl Med"},{"key":"499_CR121","doi-asserted-by":"publisher","first-page":"e0006967","DOI":"10.1371\/journal.pntd.0006967","volume":"13","author":"ME Haziot","year":"2019","unstructured":"Haziot ME, Gascon MR, Assone T, Fonseca LAM, Luiz ODC, Smid J, Paiva AM, Marcusso R, de Oliveira ACP, Casseb J. Detection of clinical and neurological signs in apparently asymptomatic HTLV-1 infected carriers: association with high proviral load. PLoS Negl Trop Dis. 2019;13:e0006967.","journal-title":"PLoS Negl Trop Dis"},{"key":"499_CR122","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/civ229","volume":"61","author":"D Tanajura","year":"2015","unstructured":"Tanajura D, Castro N, Oliveira P, Neto A, Muniz A, Carvalho NB, Orge G, Santos S, Glesby MJ, Carvalho EM. Neurological manifestations in human T-cell lymphotropic virus type 1 (HTLV-1)-infected individuals without HTLV-1-associated myelopathy\/tropical spastic paraparesis: a longitudinal cohort study. Clin Infect Dis. 2015;61:49\u201356.","journal-title":"Clin Infect Dis"},{"key":"499_CR123","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.antiviral.2013.05.006","volume":"99","author":"T Alfahad","year":"2013","unstructured":"Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res. 2013;99:180\u20137.","journal-title":"Antiviral Res"},{"key":"499_CR124","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3109\/13550280009091955","volume":"6","author":"T Matsuzaki","year":"2000","unstructured":"Matsuzaki T, Nakagawa M, Nagai M, Nobuhara Y, Usuku K, Higuchi I, Takahashi K, Moritoyo T, Arimura K, Izumo S, et al. HTLV-I-associated myelopathy (HAM)\/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol. 2000;6:544\u20138.","journal-title":"J Neurovirol"},{"key":"499_CR125","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1212\/01.wnl.0000180962.47653.5e","volume":"65","author":"MT Silva","year":"2005","unstructured":"Silva MT, Leite AC, Alamy AH, Chimelli L, Andrada-Serpa MJ, Araujo AQ. ALS syndrome in HTLV-I infection. Neurology. 2005;65:1332\u20133.","journal-title":"Neurology"},{"key":"499_CR126","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1016\/j.transproceed.2018.08.031","volume":"50","author":"S Nayar","year":"2018","unstructured":"Nayar S, Pawar B, Einsiedel L, Fernandes D, George P, Thomas S, Sajiv C. Isolated neurogenic bladder associated with human T-lymphotropic virus type 1 infection in a renal transplant patient from central Australia: a case report. Transplant Proc. 2018;50:3940\u20132.","journal-title":"Transplant Proc"},{"key":"499_CR127","first-page":"49","volume":"4","author":"AR Panfil","year":"2013","unstructured":"Panfil AR, Al-Saleem JJ, Green PL. Animal models utilized in HTLV-1 research. Virology. 2013;4:49\u201359.","journal-title":"Virology"},{"key":"499_CR128","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.176.4.981","volume":"176","author":"N Ishiguro","year":"1992","unstructured":"Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, Yoshiki T. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy\/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med. 1992;176:981\u20139.","journal-title":"J Exp Med"},{"key":"499_CR129","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1349-7006.1993.tb02052.x","volume":"84","author":"S Kushida","year":"1993","unstructured":"Kushida S, Matsumura M, Tanaka H, Ami Y, Hori M, Kobayashi M, Uchida K, Yagami K, Kameyama T, Yoshizawa T, et al. HTLV-1-associated myelopathy\/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats. Jpn J Cancer Res. 1993;84:831\u20133.","journal-title":"Jpn J Cancer Res"},{"key":"499_CR130","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1128\/JVI.68.11.7221-7226.1994","volume":"68","author":"S Kushida","year":"1994","unstructured":"Kushida S, Mizusawa H, Matsumura M, Tanaka H, Ami Y, Hori M, Yagami K, Kameyama T, Tanaka Y, Yoshida A, et al. High incidence of HAM\/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells. J Virol. 1994;68:7221\u20136.","journal-title":"J Virol"},{"key":"499_CR131","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1034\/j.1600-0463.2000.d01-83.x","volume":"108","author":"O Ohya","year":"2000","unstructured":"Ohya O, Ikeda H, Tomaru U, Yamashita I, Kasai T, Morita K, Wakisaka A, Yoshiki T. Human T-lymphocyte virus type I (HTLV-I)-induced myeloneuropathy in rats: oligodendrocytes undergo apoptosis in the presence of HTLV-I. APMIS. 2000;108:459\u201366.","journal-title":"APMIS"},{"issue":"Suppl 3","key":"499_CR132","first-page":"255","volume":"11","author":"O Ohya","year":"1997","unstructured":"Ohya O, Tomaru U, Yamashita I, Kasai T, Morita K, Ikeda H, Wakisaka A, Yoshiki T. HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis. Leukemia. 1997;11(Suppl 3):255\u20137.","journal-title":"Leukemia"},{"key":"499_CR133","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/13550280390241160","volume":"9","author":"U Tomaru","year":"2003","unstructured":"Tomaru U, Ikeda H, Jiang X, Ohya O, Yoshiki T. Provirus expansion and deregulation of apoptosis-related genes in the spinal cord of a rat model for human T-lymphocyte virus type I-associated myeloneuropathy. J Neurovirol. 2003;9:530\u20138.","journal-title":"J Neurovirol"},{"key":"499_CR134","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2353\/ajpath.2006.051225","volume":"169","author":"Y Miyatake","year":"2006","unstructured":"Miyatake Y, Ikeda H, Ishizu A, Baba T, Ichihashi T, Suzuki A, Tomaru U, Kasahara M, Yoshiki T. Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1. Am J Pathol. 2006;169:189\u201399.","journal-title":"Am J Pathol"},{"key":"499_CR135","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s004010050962","volume":"97","author":"T Kasai","year":"1999","unstructured":"Kasai T, Ikeda H, Tomaru U, Yamashita I, Ohya O, Morita K, Wakisaka A, Matsuoka E, Moritoyo T, Hashimoto K, et al. A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia\/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy. Acta Neuropathol. 1999;97:107\u201312.","journal-title":"Acta Neuropathol"},{"key":"499_CR136","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11481-017-9740-y","volume":"12","author":"R Ginwala","year":"2017","unstructured":"Ginwala R, Caruso B, Khan ZK, Pattekar A, Chew GM, Corley MJ, Loonawat R, Jacobson S, Sreedhar S, Ndhlovu LC, Jain P. HTLV-1 infection and neuropathogenesis in the context of Rag1(\u2212\/\u2212)gammac(\u2212\/\u2212) (RAG1-Hu) and BLT mice. J Neuroimmune Pharmacol. 2017;12:504\u201320.","journal-title":"J Neuroimmune Pharmacol"},{"key":"499_CR137","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/13550289609146899","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol. 1996;2:345\u201355.","journal-title":"J Neurovirol"},{"key":"499_CR138","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology. 1996;46:1016\u201321.","journal-title":"Neurology"},{"key":"499_CR139","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ana.20429","volume":"57","author":"U Oh","year":"2005","unstructured":"Oh U, Yamano Y, Mora CA, Ohayon J, Bagnato F, Butman JA, Dambrosia J, Leist TP, McFarland H, Jacobson S. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease. Ann Neurol. 2005;57:526\u201334.","journal-title":"Ann Neurol"},{"key":"499_CR140","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ana.410440613","volume":"44","author":"TJ Lehky","year":"1998","unstructured":"Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, et al. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy\/tropical spastic paraparesis patients treated with humanized anti-Tac. Ann Neurol. 1998;44:942\u20137.","journal-title":"Ann Neurol"},{"key":"499_CR141","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1704827","volume":"378","author":"T Sato","year":"2018","unstructured":"Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, et al. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy. N Engl J Med. 2018;378:529\u201338.","journal-title":"N Engl J Med"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-019-0499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-019-0499-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-019-0499-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T13:42:03Z","timestamp":1695476523000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-019-0499-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["499"],"URL":"https:\/\/doi.org\/10.1186\/s12977-019-0499-5","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}